Rosmarinic acid inhibits migration, invasion, and p38/AP-1 signaling via miR-1225-5p in colorectal cancer cells

References

• Zhu J, Tan Z, Hollis-Hansen K, et al. Epidemiological trends in colorectal cancer in China: an ecological study. Dig Dis Sci. 2017;62(1):235–243.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.
   PubMed Web of Science ®Google Scholar
• Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9(2):102–114.
   PubMed Web of Science ®Google Scholar
• Banaudha KK, Verma M. The role of microRNAs in the management of liver cancer. Methods Mol Biol. 2012;863:241–251.
   PubMedGoogle Scholar
• Zheng H, Zhang F, Lin X, et al. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling. Oncotarget. 2016;7(4):4647–4663.
   PubMedGoogle Scholar
• Sun P, Zhang D, Huang H, et al. MicroRNA-1225-5p acts as a tumor-suppressor in laryngeal cancer via targeting CDC14B. Biol Chem. 2019;400(2):237–246.
   PubMed Web of Science ®Google Scholar
• Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, et al. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci USA. 2004;101(7):2040–2045.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Suzuki T, Kobayashi A, et al. Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol Cell Biol. 2008;28(8):2758–2770.
   PubMed Web of Science ®Google Scholar
• Ryoo IG, Ha H, Kwak MK. Inhibitory role of the KEAP1-NRF2 pathway in TGFβ1-stimulated renal epithelial transition to fibroblastic cells: a modulatory effect on SMAD signaling. PLoS One. 2014;9(4):e93265
   PubMed Web of Science ®Google Scholar
• Oh CJ, Kim JY, Choi YK, et al. Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling. PLoS One. 2012;7(10):e45870.
   PubMed Web of Science ®Google Scholar
• Munshi A, Ramesh R. Mitogen-activated protein kinases and their role in radiation response. Genes Cancer. 2013;4(9-10):401–408.
   PubMedGoogle Scholar
• Yeung YT, Bryce NS, Adams S, et al. p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells. J Neurooncol. 2012;109(1):35–44.
   PubMed Web of Science ®Google Scholar
• Cao L, Chen X, Xiao X, et al. Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways. Int J Oncol. 2016;49(2):735–743.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Liu S, Zhang Q, et al. Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironment. Prostate. 2014;74(8):869–879.
   PubMed Web of Science ®Google Scholar
• Li S, Cong X, Gao H, et al. Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells. J Exp Clin Cancer Res. 2019;38(1):6.
   PubMedGoogle Scholar
• Wu Z, He D, Zhao S, et al. IL-17A/IL-17RA promotes invasion and activates MMP-2 and MMP-9 expression via p38 MAPK signaling pathway in non-small cell lung cancer. Mol Cell Biochem. 2019;455(1-2):195–206.
   PubMed Web of Science ®Google Scholar
• Kim GD, Park YS, Jin YH, et al. Production and applications of rosmarinic acid and structurally related compounds. Appl Microbiol Biotechnol. 2015;99(5):2083–2092.
   PubMed Web of Science ®Google Scholar
• Reziwan K, Sun D, Zhang B, et al. MicroRNA-1225 activates Keap1-Nrf2-HO-1 signalling to inhibit TNFα-induced osteoclastogenesis by mediating ROS generation . Cell Biochem Funct. 2019; 37(4):256–265.
   PubMed Web of Science ®Google Scholar
• Chen B, Lu Y, Chen Y, et al. The role of Nrf2 in oxidative stress-induced endothelial injuries. J Endocrinol. 2015;225(3):R83–99.
   PubMed Web of Science ®Google Scholar
• Loboda A, Damulewicz M, Pyza E, et al. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016;73(17):3221–3247.
   PubMed Web of Science ®Google Scholar
• Chaiprasongsuk A, Lohakul J, Soontrapa K, et al. Activation of Nrf2 reduces UVA-mediated MMP-1 upregulation via MAPK/AP-1 signaling cascades: the photoprotective effects of sulforaphane and hispidulin. J Pharmacol Exp Ther. 2017;360(3):388–398.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen Z, Li J. The current status of treatment for colorectal cancer in China: A systematic review. Medicine (Baltimore). 2017;96(40):e8242
   PubMed Web of Science ®Google Scholar
• Gansler T, Ganz PA, Grant M, et al. Sixty years of CA: a cancer journal for clinicians. CA Cancer J Clin. 2010;60(6):345–350.
   PubMed Web of Science ®Google Scholar
• Zhang GY, Yang WH, Chen Z. Upregulated STAT3 and RhoA signaling in colorectal cancer (CRC) regulate the invasion and migration of CRC cells. Eur Rev Med Pharmacol Sci. 2016;20(10):2028–2037.
   PubMed Web of Science ®Google Scholar
• Yan S, Cao Y, Mao A. MicroRNAs in colorectal cancer: potential biomarkers and therapeutic targets. Front Biosci (Landmark Ed). 2015;20:1092–1103.
   PubMed Web of Science ®Google Scholar
• Li JM, Zhao RH, Li ST, et al. Down-regulation of fecal miR-143 and miR-145 as potential markers for colorectal cancer. Saudi Medical Journal. 2012;33(1):24–29.
   PubMed Web of Science ®Google Scholar
• Liu L, Chen L, Xu Y, et al. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem Biophys Res Commun. 2010;400(2):236–240.
   PubMed Web of Science ®Google Scholar
• Hansen TF, Nielsen BS, Jakobsen A, et al. Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study. J Transl Med. 2015;13(1):10.
   PubMedGoogle Scholar
• Zheng YB, Xiao K, Xiao GC, et al. MicroRNA-103 promotes tumor growth and metastasis in colorectal cancer by directly targeting LATS2. Oncol Lett. 2016;12(3):2194–2200.
   PubMed Web of Science ®Google Scholar
• Wang S, Chen X, Zhang Z, et al. MicroRNA-1225-5p inhibits the development and progression of thyroid cancer via targeting sirtuin 3. Pharmazie. 2019;74(7):423–427.
   PubMed Web of Science ®Google Scholar
• Li D, Chi G, Chen Z, et al. MicroRNA-1225-5p behaves as a tumor suppressor in human glioblastoma via targeting of IRS1. Onco Targets Ther. 2018;11:6339–6350.
   PubMed Web of Science ®Google Scholar
• Bocci F, Tripathi SC, Vilchez Mercedes SA, et al. NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype. Integr Biol (Camb). 2019;11(6):251–263.
   PubMed Web of Science ®Google Scholar
• Rajasekaran S, Rajaguru P, Sudhakar Gandhi PS. MicroRNAs as potential targets for progressive pulmonary fibrosis. Front Pharmacol. 2015;6:254.
   PubMed Web of Science ®Google Scholar
• Ning L, Wan S, Jie Z, et al. Lycorine induces apoptosis and G1 phase arrest through ROS/p38 MAPK signaling pathway in human osteosarcoma cells in vitro and in vivo. Spine. 2020;45(3):E126–E139.
   PubMed Web of Science ®Google Scholar
• Sato A, Okada M, Shibuya K, et al. Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells. Stem Cell Res. 2014;12(1):119–131.
   PubMed Web of Science ®Google Scholar
• Jahanban-Esfahlan R, Seidi K, Manjili MH, et al. Tumor cell dormancy: threat or opportunity in the fight against cancer. Cancers. 2019;11(8):1207.
   Web of Science ®Google Scholar
• Shay G, Lynch CC, Fingleton B. Moving targets: emerging roles for MMPs in cancer progression and metastasis. Matrix Biol. 2015;44-46:200–206.
   PubMed Web of Science ®Google Scholar
• Yan Q, Bach DQ, Gatla N, et al. Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma. Mol Cancer Res. 2013;11(6):665–675.
   PubMed Web of Science ®Google Scholar
• Ozanne BW, McGarry L, Spence HJ, et al. Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme. Eur J Cancer. 2000;36(13 Spec No):1640–1648.
   PubMed Web of Science ®Google Scholar
• Amoah SK, Sandjo LP, Kratz JM, et al. Rosmarinic acid-pharmaceutical and clinical aspects. Planta Med. 2016;82(5):388–406.
   PubMed Web of Science ®Google Scholar
• Han Y, Ma L, Zhao L, et al. Rosmarinic inhibits cell proliferation, invasion and migration via up-regulating miR-506 and suppressing MMP2/16 expression in pancreatic cancer. Biomed Pharmacother. 2019;115:108878.
   PubMed Web of Science ®Google Scholar